Current Trends in Bioterrorism and Biodefense

Abstract

ISSN:2157-2526 JBTBD, an open access journal Advances in Biosciences: Bioterrorism J Bioterr Biodef Current trends in bioterrorism and biodefense research have resulted in the realization of cheap, effective and powerful methods of both detection and protection based biodefense strategies. For the first time, the U.S. FDA has approved a monoclonal antibody (mAb) for antibacterial uses: ABthrax for treatment of inhalational anthrax [1]. This event suggests exciting new trends in the licensing and commercial production of novel prophylactic technologies. To foster further development of emerging technologies, it is essential that funding for research programs which contribute to public health and safety remains a high priority.